Low incidence and prevalence of hepatitis C in two cohorts of HIV pre-exposure prophylaxis adherence interventions in men who have sex with men in Southern California

J Viral Hepat. 2022 Jul;29(7):529-535. doi: 10.1111/jvh.13678. Epub 2022 Apr 12.

Abstract

HIV pre-exposure prophylaxis (PrEP) has been associated with incident hepatitis C virus (HCV) infection in men who have sex with men (MSM) due to decreased condom use. We examined rates of HCV among MSM and transgender women at high-risk of HIV on PrEP in Southern California using data from two trials (NCT01761643 and NCT01781806). Five of 599 participants (0.84%, 95% CI, 0.27-1.93) had HCV antibodies detected at entry. Factors associated with HCV seropositivity included being older (p = .002) and lower education level (p < .001). HCV-positive participants had no reported cases of sexually transmitted infection (rectal, urethral or pharyngeal gonorrhoea and/or chlamydia) at entry while HCV-negative participants had a prevalence of 18% (95% CI, 15%-21%). There were no significant differences in substance use and sexual risk behaviour between HCV-positive and HCV-negative participants 1-3 months prior to entry. Among early PrEP adopters, incident HCV did not occur despite ongoing condomless intercourse. Screening intervals for HCV in MSM on PrEP should be led by a risk behaviour assessment.

Keywords: MSM (men who have sex with men); PrEP; hepatitis C.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Clinical Trials as Topic
  • Female
  • HIV Infections* / epidemiology
  • HIV Infections* / prevention & control
  • Hepacivirus
  • Hepatitis C* / epidemiology
  • Hepatitis C* / prevention & control
  • Homosexuality, Male
  • Humans
  • Incidence
  • Male
  • Pre-Exposure Prophylaxis*
  • Prevalence
  • Sexual Behavior
  • Sexual and Gender Minorities*